GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Isleworth Healthcare Acquisition Corp (NAS:ISLEW) » Definitions » Notes Receivable

Switch to:

ISLEW (Isleworth Healthcare Acquisition) Notes Receivable : $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Isleworth Healthcare Acquisition Notes Receivable?

Isleworth Healthcare Acquisition's Notes Receivable for the quarter that ended in Jun. 2022 was $0.00 Mil.

Isleworth Healthcare Acquisition Notes Receivable Historical Data

The historical data trend for Isleworth Healthcare Acquisition's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isleworth Healthcare Acquisition Notes Receivable Chart

Isleworth Healthcare Acquisition Annual Data

Trend

Dec20

Dec21

Notes Receivable

-

-

Isleworth Healthcare Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Notes Receivable	Get a 7-Day Free Trial			-	-	-	-	-

Isleworth Healthcare Acquisition Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Isleworth Healthcare Acquisition Notes Receivable Related Terms

Thank you for viewing the detailed overview of Isleworth Healthcare Acquisition's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Isleworth Healthcare Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Isleworth Healthcare Acquisition Corp (NAS:ISLEW) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 Central Avenue, First Central Tower, Suite No. 800, Saint Petersburg, FL, USA, 33701

Website

https://www.isleworthhealthcare.com

Isleworth Healthcare Acquisition Corp is a blank check company.

Isleworth Healthcare Acquisition Headlines

From GuruFocus

Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK� Cell Engager at EHA 2022 Congress

By PRNewswire PRNewswire • 07-07-2022

Isleworth Healthcare Acquisition Corp. Announces Closing of $207,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option

By PRNewswire PRNewswire • 03-03-2021

Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK� Cell Engager at EHA 2022 Congress

By PRNewswire PRNewswire • 05-18-2022

Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK� Cell Engager at EHA 2022 Congress

By PRNewswire PRNewswire • 06-27-2022

Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer

By PRNewswire PRNewswire • 05-16-2022

Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer

By PRNewswire PRNewswire • 06-15-2022

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK� Cell Engager antibody at EHA 2022 Congress

By PRNewswire PRNewswire • 06-30-2022

Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer

By PRNewswire PRNewswire • 06-05-2022

Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK� Cell Engager at EHA 2022 Congress

By PRNewswire PRNewswire • 05-28-2022

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK� Cell Engager antibody at EHA 2022 Congress

By PRNewswire PRNewswire • 06-20-2022

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.